Prediction of recurrence from metabolites and expression of TOP2A and EZH2 in prostate cancer patients treated with radiotherapy.

NMR in biomedicine(2023)

引用 4|浏览6
暂无评分
摘要
Using an integrated approach, our study shows the potential of citrate and the dual upregulation of TOP2A and EZH2 as biomarkers for recurrence among radiotherapy patients.
更多
查看译文
关键词
EZH2,HR-MAS,TOP2A,citrate,prostate cancer,radiotherapy,recurrence
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要